Chemistry
Equilibrium Dialysis for Measuring Drug-Protein Binding
Quick fact
Equilibrium dialysis is considered the gold standard for measuring drug-protein binding because it directly determines the unbound (free) drug concentration, the species that is pharmacologically active, with minimal perturbation to the binding equilibrium.
Why this is interesting
When a drug enters your bloodstream, it quickly latches onto proteins, but how do scientists measure this invisible embrace? Equilibrium dialysis is the classic technique that untangles the free from the bound, revealing the true concentration that acts on your body.
Read the full explanation
Understanding Equilibrium Dialysis for Measuring Drug-Protein Binding
Imagine a two-chamber container divided by a membrane with tiny holes. The holes are small enough to let small molecules like a drug pass through, but too small for larger proteins. You place the protein (e.g., albumin) in one chamber and the drug in the other. Over time, the free drug molecules move across the membrane. Some of them bind to the protein, effectively trapping them in that chamber. After a while, the system reaches equilibrium: the rate of drug crossing the membrane from one side equals the rate crossing back. At this point, the concentration of free (unbound) drug is the same on both sides, because the membrane only sees free drug. However, the total drug concentration in the protein chamber is higher because it includes the bound drug. By measuring the total drug in both chambers, you can subtract the free concentration (from the protein-free chamber) and calculate how much is bound. This gives you the bound fraction, a key number that tells you how much of the drug is available to act on tissues versus being held in the bloodstream.
A deeper explanation
The power of equilibrium dialysis lies in its simplicity and thermodynamic rigor. The membrane acts as a selective filter that separates bound from free drug. Because the membrane is permeable only to the free drug, at equilibrium the chemical potential of the free drug is equal on both sides. Thus, the concentration of free drug in the protein-free compartment equals the free concentration in the protein-containing compartment. This allows a direct measurement of [free drug]. The bound concentration is then [total drug in protein side] – [free drug]. By performing this at various drug concentrations, you can construct a binding isotherm. The shape of this isotherm reflects the binding affinity (Kd) and the number of binding sites per protein molecule. For a simple one-site system, the fraction bound follows a hyperbolic curve, and analysis with a Scatchard plot or nonlinear regression yields the association constant (Ka) and the binding capacity. This quantitative information is vital for predicting drug interactions, therapeutic windows, and dosing intervals. The technique’s limitations—such as long equilibration times and non-specific binding to the membrane—must be managed, but it remains the benchmark against which other methods are compared.